A group of researchers led by Prof. NISHIDA Kohji of Osaka University transplanted iPS cells-derived corneal epithelial cell sheets into a patient with corneal disorders in July 2019.
This is the first clinical study of cornea regeneration using iPS to examine the safety and effects of sheet-shaped corneal epithelial cells, which are cultivated by inducing corneal epithelial cells using iPS cells from others (provided by the Center for iPS Cell Research and Application (CiRA), Kyoto University), with their own method. The status of the patient, who was discharged from hospital on August 23, 2019, will be continually monitored.
Corneal epithelial stem cell deficiency caused by damage to the corneal epithelium has challenges, such as donor shortage and rejection in recipients of transplants using donor corneas. In order to ultimately solve these challenges, the research group has advanced the development of regenerative therapies using hiPS-derived corneal cells.